{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:08:31Z","timestamp":1785434911325,"version":"3.56.0"},"posted":{"date-parts":[[2026,7,27]]},"group-title":"Neurology","reference-count":32,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["R01-AG87140, R01-DC12519 and R01-NS89757"],"award-info":[{"award-number":["R01-AG87140, R01-DC12519 and R01-NS89757"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Corticobasal syndrome (CBS) is a neurodegenerative syndrome that often results from a 4-repeat tauopathy. Abnormalities on tau PET, structural MRI, and diffusion MRI (dMRI) have been observed in CBS, although no prior work has systematically compared the relative sensitivity of these modalities. In addition, the relationships between tau uptake, volume loss, and white matter degeneration remain incompletely understood.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To compare the sensitivity of tau PET, structural volume, and dMRI metrics to differentiate CBS from controls, and to characterize relationships between regional tau uptake, volume loss, and white matter tract abnormalities.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    Thirty-two participants meeting criteria for possible or probable CBS and 35 healthy controls underwent standardized 3T dMRI,\n                    <jats:sup>18<\/jats:sup>\n                    F-flortaucipir tau PET, and detailed neurologic assessment. Diffusion data were processed using complementary diffusion tensor, free-water, and Neurite Orientation Dispersion and Density Imaging (NODDI) pipelines, with tract-level metrics extracted using the Johns Hopkins University-Eve (JHU EVE) White Matter atlas. Regional gray matter volumes and flortaucipir standardized uptake value ratios (SUVRs) were calculated. Global tau PET uptake, represented by the first principal component (PC1), was removed in a secondary tau analysis. Modality-level discrimination was assessed using area under the curve (AUC) analyses. Cross-modality relationships were evaluated using regional correlations and covariate-adjusted models comparing volume- and tau-related predictors of white matter abnormalities.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Relative to controls, CBS showed widespread higher mean diffusivity (MD) and lower intracellular volume fraction (ICVF), especially in sensorimotor and projection white matter pathways. Structural volume reductions were most prominent in precentral cortex and subcortical regions including putamen, thalamus, and pallidum, whereas tau PET abnormalities were weaker and less spatially extensive. MD showed the strongest overall discrimination between CBS and controls, followed by ICVF, structural volume, PC1-removed tau PET, and original tau PET. In targeted sensorimotor analyses, higher DTI-MD was most strongly associated with lower gray matter volume. PC1-removed sensorimotor tau uptake was also associated with higher sensorimotor DTI-MD, whereas original tau uptake and broader cortical or subcortical tau measures were not significant predictors.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>White matter microstructural disruption is a dominant imaging signature of CBS and is more closely linked to gray matter volume loss than to measurable uptake on tau PET. dMRI, particularly MD and ICVF, may provide greatest sensitivity for detecting disease-related changes in CBS.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.07.24.26358494","type":"posted-content","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:20:19Z","timestamp":1785180019000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffusion MRI Is More Sensitive Than Tau PET and Regional Volume Loss in Corticobasal Syndrome"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3156-7486","authenticated-orcid":false,"given":"Yuqi","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val J.","family":"Lowe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Josephs","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Whitwell","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"issue":"1","key":"2026072905350540000_2026.07.24.26358494v1.1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","article-title":"Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue","volume":"7","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"2026072905350540000_2026.07.24.26358494v1.2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00415-018-8815-x","article-title":"[(18)F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation","volume":"265","year":"2018","journal-title":"J Neurol"},{"key":"2026072905350540000_2026.07.24.26358494v1.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31827f0fd1"},{"key":"2026072905350540000_2026.07.24.26358494v1.4","doi-asserted-by":"publisher","DOI":"10.1006\/jmrb.1996.0086"},{"key":"2026072905350540000_2026.07.24.26358494v1.5","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.6.796"},{"key":"2026072905350540000_2026.07.24.26358494v1.6","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.1.81"},{"key":"2026072905350540000_2026.07.24.26358494v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2014.10.026"},{"key":"2026072905350540000_2026.07.24.26358494v1.8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.11.1621"},{"key":"2026072905350540000_2026.07.24.26358494v1.9","first-page":"8","article-title":"Dipy, a library for the analysis of diffusion MRI data","volume":"8","year":"2014","journal-title":"Front Neuroinform"},{"issue":"3","key":"2026072905350540000_2026.07.24.26358494v1.10","doi-asserted-by":"crossref","first-page":"e70018","DOI":"10.1002\/alz.70018","article-title":"Relationships between hypometabolism and both \u03b2-amyloid and tau PET in corticobasal syndrome","volume":"21","year":"2025","journal-title":"Alzheimers Dement"},{"key":"2026072905350540000_2026.07.24.26358494v1.11","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"2026072905350540000_2026.07.24.26358494v1.12","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm032"},{"key":"2026072905350540000_2026.07.24.26358494v1.13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"issue":"3","key":"2026072905350540000_2026.07.24.26358494v1.14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","article-title":"Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome","volume":"77","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10","key":"2026072905350540000_2026.07.24.26358494v1.15","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamaneurol.2019.1971","article-title":"Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer\u2019s Association Research Framework","volume":"76","year":"2019","journal-title":"JAMA Neurol"},{"key":"2026072905350540000_2026.07.24.26358494v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.08.005"},{"key":"2026072905350540000_2026.07.24.26358494v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2006.09.019"},{"key":"2026072905350540000_2026.07.24.26358494v1.18","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.1076"},{"issue":"1","key":"2026072905350540000_2026.07.24.26358494v1.19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","article-title":"An autoradiographic evaluation of AV-1451 Tau PET in dementia","volume":"4","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"2026072905350540000_2026.07.24.26358494v1.20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.parkreldis.2022.04.015","article-title":"PET-based classification of corticobasal syndrome","volume":"98","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"key":"2026072905350540000_2026.07.24.26358494v1.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"issue":"1","key":"2026072905350540000_2026.07.24.26358494v1.22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mds.70070","article-title":"A Biomarker-Based Classification of Corticobasal Syndrome","volume":"41","author":"T. German Imaging Initiative for","year":"2026","journal-title":"Mov Disord"},{"issue":"11","key":"2026072905350540000_2026.07.24.26358494v1.23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","article-title":"Characterization of tau positron emission tomography tracer [(18)F]AV-1451 binding to postmortem tissue in Alzheimer\u2019s disease, primary tauopathies, and other dementias","volume":"12","year":"2016","journal-title":"Alzheimers Dement"},{"key":"2026072905350540000_2026.07.24.26358494v1.24","doi-asserted-by":"crossref","first-page":"120509","DOI":"10.1016\/j.neuroimage.2024.120509","article-title":"Direct comparison between (18)F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy","volume":"286","year":"2024","journal-title":"Neuroimage"},{"key":"2026072905350540000_2026.07.24.26358494v1.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.271019"},{"key":"2026072905350540000_2026.07.24.26358494v1.26","doi-asserted-by":"publisher","DOI":"10.1044\/jshd.4503.308"},{"issue":"8","key":"2026072905350540000_2026.07.24.26358494v1.27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/WNL.0000000000004264","article-title":"In vivo retention of 18F-AV-1451 in corticobasal syndrome","volume":"89","year":"2017","journal-title":"Neurology"},{"key":"2026072905350540000_2026.07.24.26358494v1.28","doi-asserted-by":"crossref","unstructured":"Tian, Y. , F. Ali , M. M. Machulda , K. A. Josephs and J. L. Whitwell (2026). \u201cMulti-model Diffusion MRI Signatures in Atypical Parkinsonian Disorders.\u201d medRxiv.","DOI":"10.64898\/2026.02.05.26345656"},{"key":"2026072905350540000_2026.07.24.26358494v1.29","doi-asserted-by":"crossref","first-page":"121984","DOI":"10.1016\/j.neuroimage.2026.121984","article-title":"Advanced diffusion MRI tract signatures in Alzheimer\u2019s disease, dementia with Lewy bodies, and the FTD\/PPA spectrum","volume":"334","year":"2026","journal-title":"Neuroimage"},{"key":"2026072905350540000_2026.07.24.26358494v1.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02741.x"},{"key":"2026072905350540000_2026.07.24.26358494v1.31","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.107"},{"key":"2026072905350540000_2026.07.24.26358494v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2012.03.072"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.07.24.26358494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:35:16Z","timestamp":1785328516000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.07.24.26358494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":32,"URL":"https:\/\/doi.org\/10.64898\/2026.07.24.26358494","relation":{},"subject":[],"published":{"date-parts":[[2026,7,27]]},"subtype":"preprint"}}